0001209191-23-047062.txt : 20230823
0001209191-23-047062.hdr.sgml : 20230823
20230823162840
ACCESSION NUMBER: 0001209191-23-047062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230822
FILED AS OF DATE: 20230823
DATE AS OF CHANGE: 20230823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chudnovsky Yekaterina
CENTRAL INDEX KEY: 0001979324
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41159
FILM NUMBER: 231197942
MAIL ADDRESS:
STREET 1: C/O ELICIO THERAPEUTICS, INC.
STREET 2: 451 D STREET, 5TH FLOOR, SUITE 501
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immix Biopharma, Inc.
CENTRAL INDEX KEY: 0001873835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454869378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11400 WEST OLYMPIC BLVD.
STREET 2: SUITE 200
CITY: LOS ANGELES
STATE: CA
ZIP: 90064
BUSINESS PHONE: (888) 958-1084
MAIL ADDRESS:
STREET 1: 10573 W. PICO BLVD.
STREET 2: #58
CITY: LOS ANGELES
STATE: CA
ZIP: 90064
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-22
0
0001873835
Immix Biopharma, Inc.
IMMX
0001979324
Chudnovsky Yekaterina
C/O IMMIX BIOPHARMA, INC.
11400 WEST OLYMPIC BLVD., SUITE 200
LOS ANGELES
CA
90064
1
0
1
0
0
Stock Option (Right to Buy)
1.80
2023-08-22
4
A
0
20000
0.00
A
2033-08-22
Common Stock
20000
20000
D
Stock Option (Right to Buy)
1.80
2023-08-22
4
A
0
16670
0.00
A
2033-08-22
Common Stock
16670
16670
D
The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.
The Stock Option will vest in ten (10) equal monthly installments following the date of grant and any remaining unvested shares will become fully vested and exercisable on the date of the 2024 annual shareholder meeting, subject to the Reporting Person's continued service on the Board of Directors.
/s/ Yekaterina Chudnovsky
2023-08-23